Hantz Financial Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Hantz Financial Services's GILD Position: Q1 2026 in Review
Hantz Financial Services increased its Gilead Sciences (GILD) stake by 1.4% in Q1 2026, buying an estimated $53.6K and bringing the position to 27,376 shares worth $3.81M. The position accounts for 0.06% of the portfolio, ranked #226.
Hantz Financial Services first reported a position in GILD in Q1 2020 and has held it in 25 quarters since. The position peaked at $8.44M in Q4 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Hantz Financial Services held 27,376 shares of Gilead Sciences worth $3.81M as of Q1 2026.
- Hantz Financial Services bought 383 Gilead Sciences shares in Q1 2026, an estimated $53.6K.
- Gilead Sciences made up 0.06% of Hantz Financial Services's portfolio in Q1 2026, its #226 holding.
- Hantz Financial Services first reported a position in Gilead Sciences in Q1 2020 and has held it in 25 quarters since.
- Hantz Financial Services's Gilead Sciences position peaked at $8.44M in Q4 2023.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.